INTRODUCTION
Liver transplantation remains the only effective treatment for liver failure. However, its clinical application is limited by donor organs and immune rejection. To this end, hepatocyte transplantation and a bio-artificial liver support system are two potential surrogate complementary therapies for patients with liver failure. Hepatocyte-like cells can be induced from mesenchymal stem cells (MSCs) for xenotransplantation and have been demonstrated to perform hepatocyte functions in preclinical animal studies [1, 2] . However, the best type of MSC has not yet been investigated, and therefore it is important to screen for an ideal seed cell type for cell transplantation or a bio-artificial liver support system.
MSCs are non-hematopoietic multipotent stem cells that can be isolated from multiple tissues, such as bone marrow, adipose tissue, cord blood, and amniotic fluid [3] [4] [5] . Bone marrow stromal cells (BMSCs) are the most extensively studied and fertile stem cell source used in regenerative medicine and liver tissue engineering [6, 7] . More recently, adipose-derived stromal cells (ADSCs) were identified as another promising and extensively studied stem cells for use, especially in liver tissue engineering [8] . Although both ADSCs and BMSCs can be induced into hepatocyte-like cells [9] [10] [11] [12] , there is no uniform culture system to evaluate their hepatic differentiation potential. Therefore, it is necessary to establish an ideal system to improve the efficiency of hepatic induction.
In this study, we developed a novel culture protocol for mouse BMSCs and optimized the hepatic differentiation system. We compared the morphological and phenotypic characteristics, as well as the multidifferentiation capacity of BMSCs and ADSCs in vitro. We also compared therapeutic effect of BMSCs and ADSCs following transplantation into a mouse model of acute liver failure.
MATERIALS AND METHODS

Experimental animals
Male BALB/c mice (3 d old and 6 wk old; Charles River, Beijing, China) were purchased from the Laboratory Animal Center of the Academy of Military Medical Sciences of China (Beijing). All studies were conducted after approved by the Ethics Committee of the Animal Facility of Chinese PLA General Hospital and complied with the guidelines for the care of laboratory animals. Mice were housed in cages in a controlled environment (25 ℃ and a 12 h light/dark cycle) and fed standard mouse chow and tap water, and were observed every day in our animal facility.
Isolation and purification of adipose-derived stromal cells and bone marrow stromal cells
The isolation and purification of ADSCs were performed as previously described [13] . Fibrous tissue was excluded and adipose tissue was minced into pieces of < 1 mm 3 and digested in 1 mg/mL collagenase I for 1 h at 37 ℃. The cell suspension was filtered through a 100 µmol/L cell strainer and centrifuged at 300 × g for 5 min. ADSCs were plated at a density of 5 × 10 5 / cm 2 with alpha minimal essential medium (α-MEM)
supplemented with 10% fetal bovine serum (FBS) and 1% penicillin/streptomycin, and cultured in a humidified incubator at 37 ℃ and 5% CO2. Cells were harvested after reaching a 90% confluence with 0.25% trypsin-EDTA (Gibco, American). Cells in passages 2-4 were used for subsequent experiments.
A new method was established to isolate mouse BMSCs as follows: 3-d-old male BALB/c mice were sacrificed by cervical dislocation and soaked in 75% alcohol for 5 min. The tibia and fibula were isolated under sterile conditions and washed twice with phosphate-buffered saline (PBS) containing 5% penicillin/streptomycin. Muscle and fibrous tissue were excluded. Tibias and fibulas were minced into pieces of < 1 mm 3 and washed once with α-MEM, cultured directly by incubation with α-MEM supplemented with 10% FBS and 1% penicillin/streptomycin in a humidified incubator at 37 ℃ and 5% CO2. After 72 h, half of the medium was changed and the bone chips were kept. After reaching a 50% confluence, cells were harvested with 0.25% trypsin-EDTA and seeded as the first passage. At each passage, cells were diluted 1:3-4 every two days. BMSCs at passages 2-4 were used for subsequent experiments.
Measurement of adipose-derived stromal cells and bone marrow stromal cells proliferation
For the cell proliferation assay, 2 × 10 3 viable ADSCs and BMSCs were seeded in triplicate onto a 96-well plate. Cell proliferation was measured using a Cell Counting Kit-8 (CCK-8; Beyotime, China). Plates were placed in a humidified incubator at 37 ℃ until the cells adhered to the plate. Next, 10 µL of the CCK-8 solution was added to each well and plates were incubated for another 2 h at 37 ℃ prior to reading the absorbance at 450 nm on a microplate reader. The assay was repeated every day at the same time for 10 d.
Flow cytometry
Passage 2 and 3 ADSCs and BMSCs were trypsinized and incubated with fluorescein isothiocyanateconjugated CD45 and CD90, and phycoerythrinconjugated CD11b and CD29 antibodies for 30 min at 4 ℃, followed by two washes with PBS. Fluorescentlabeled cells were analyzed on a flow cytometer. 
Differentiation assays
Reverse transcription polymerase chain reaction
On day 10 of hepatic differentiation, total RNA was isolated from ADSCs and BMSCs with Trizol reagent illumination fluorescence microscope.
Transplantation
Six-week-old BALB/c mice were used for the transplantation experiment. An acute liver failure model was established by administering one dose of CCl4. Mice received intraperitoneal injection of 100 μL/20 g body weight of olive oil containing 10 μL CCl4 24 h before MSC transplantation. On day 0, mice underwent MSC transplantation at a concentration of 1 × 10 6 cells per mouse (0.2 mL cell suspension was injected via the tail vein). As a control, PBS-transplanted CCl4-treated mice and non-transplanted olive oil-treated mice were used. Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels were measured on days 1, 2, 3, and 7 after transplantation. Liver tissue samples were harvested at the indicated time points after cell transplantation, fixed with 4% paraformaldehyde, embedded in paraffin, and stained with hematoxylin and eosin (HE). Frozen sections (8 μm thick) were used for fluorescence observations.
Statistical analysis
Data are presented as the mean ± SD. ALT and AST levels were analyzed by Student's t test using SPSS software version 19.0 (SPSS Inc., Chicago, IL, United States). Significance for all statistical analyses was defined as P < 0.05.
RESULTS
Cellular morphology of adipose-derived stromal cells and bone marrow stromal cells
Cells were observed under an inverted microscope. On the second day of primary culture, few ADSCs were observed. On the third day, the number of cells increased (the cell density was approximately 60%) and, on the fourth day, the cells exhibited a spiralshaped structure and reached a 90% confluence. Cells were passaged at 1:3 (Supplement Figure 1A) . On the second day of primary culture (BMSCs), few fibroblast-like cells had "climbed out" around the bone fragments. The number of cells increased over time and, on the fourth day, BMSCs reached a 50% confluence and were passaged at 1:1 (Supplement Figure 1A ). From passages 1-4, the two types of MSCs were long and spindle-shaped and showed no difference in morphology (Supplement Figure 1B) .
Cell proliferation ability
The cell number of the second and third generations of the two cell types was determined over time and a growth curve was drawn. The two cell types showed active proliferative capacity, with an S-shaped growth curve. During the first three days, cells grew slowly. Between days 4 and 7, the two cell types grew rapidly and entered a logarithmic growth period. Cells (Sigma-Aldrich, St. Louis, MO, United States), reversetranscribed into first-strand cDNA using oligo (dT) primer, and amplified with 35 cycles (95 ℃, 10 min; 58 ℃, 1 min; and 72 ℃, 5 min) of PCR using 10 pmmol/L of specific primers. Upon completion of the PCR, products were examined by 2% agarose gel electrophoresis. Actin was used as an internal standard (30 cycles of amplification were performed). To compare the differences in expression levels of albumin (ALB), alpha fetoprotein (AFP), cytokeratin 18 (CK-18), CK-19, and glucose-6-phosphate (G-6-P) between undifferentiated and differentiated ADSCs and BMSCs, the products were quantified on an image analyzer (Uvitec, Warwickshire, United Kingdom). The primer sequences used are listed in Supplement Table  1 .
Western blot analysis
Western blot analysis was performed as previously described [6] . In brief, total cellular proteins were prepared and quantified by the Bradford method. Figure 1C) . There was no significant difference between the two types of adult stem cells in the same generation, and there was no significant difference between the same kinds of adult stem cells in the different generation (Supplement Table 1 ).
Phenotypic characterization of adipose-derived stromal cells and bone marrow stromal cells
ADSC and BMSC cell surface markers were analyzed by flow cytometry. Both ADSCs and BMSCs expressed the stem cell-associated surface markers CD90 and CD29, but did not express CD11b or CD45 (Supplement Table 2 ). The two cell types had a similar proliferative ability and stem cell capacity, consistent with our previous study.
Multiple differentiation ability of adipose-derived stromal cells and bone marrow stromal cells
The adipogenic and osteogenic differentiation of ADSCs and BMSCs was evaluated at passages 2 and 3. Small and round vacuoles began to appear in the cytoplasm on the third day of induction. On the 8th day, a large number of lipid droplets appeared in the majority of the induced cells and the cells became round, oval, or polygonal. Adipogenic differentiation was identified by Oil-Red-O staining, which stained the lipid vacuoles bright red. After three weeks of induction, cells aggregated in some areas and formed a multilayered, nodular structure known as a bone nodule. Osteogenic differentiation was identified by Alizarin Red staining, which stained the bone nodules red. Oil-Red-O and Alizarin Red images of such cells were shown in our previous study.
Hepatic differentiation of adipose-derived stromal cells and bone marrow stromal cells
Before differentiation, both ADSCs and BMSCs exhibited fibroblast morphology with spindle cell bodies. After differentiation, the cell morphology changed dramatically. On day 4 after hepatic differentiation, cells became round in shape. On day 7, the number of oval and polygonal cells increased, and on day 10, the induced cells exhibited a clear polygonal shape (Figure 1 ). The expression of several hepatic genes was examined after hepatic differentiation by RT-PCR. Uninduced cells served as a negative control. On day 10 after hepatic differentiation, the expression of ALB, AFP, CK-18, CK-19, and G-6-P was significantly enhanced (Figure 2A) .
The expression of ALB, AFP, CYP1A1, and CK-18 in hepatocyte-like cells was confirmed by Western blot analysis ( Figure 2B ). The expression of ALB, AFP, CYP1A1, and CK-18 increased continuously in the two types of hepatocyte-like cells compared with undifferentiated ADSCs and BMSCs, suggesting that these two types of MSCs were successfully induced into hepatocyte-like cells in vitro.
On day 10 after differentiation, immunofluorescence staining showed that the differentiated hepatocyte-like cells expressed the hepatocyte markers ALB, CK-19, CK-18, AFP, and CYP1A1 ( Figure 2C ), whereas the undifferentiated ADSCs and BMSCs ( Figure 2C ) did not express the hepatocyte-related markers.
Transplanted cells were found in damaged livers
To investigate whether the CM-Dil-labeled MSCs localized to the injured liver, animals were sacrificed on days 1, 2, 3 and 7 following treatment. In the ADSC and BMSC groups, red fluorescent cells were detected in the injured livers. In addition, the largest number of cells was detected on day 3 after transplantation and 
Both adipose-derived stromal cells and bone marrow stromal cells improved liver function
To address whether ADSCs and BMSCs can regenerate the injured mouse liver, these cell types were transplanted into liver-injured mice. Twenty-four hours after CCl4 injection, mice exhibited serious liver injury. Biochemical parameters, including ALT and AST, were measured and stem cells were transplanted. The therapeutic abilities of the two experimental groups were compared at different time points. Following transplantation, the ALT and AST levels of the (Figure 4) . HE staining revealed that the degree of injury was much weaker in the injured transplanted mice than in the injured, nontransplanted mice ( Figure 5 ). On day 7, all of the experimental groups recovered histologically. However, damaged areas were still observed in the CCl4 group. These observations indicated that ADSCs and BMSCs possessed similar repairing abilities against CCl4-induced liver injury.
DISCUSSION
MSC transplantation is a promising alternative therapy for some liver diseases.
Availability of a large number of functional hepatocytes is essential for cytotherapy. However, primary hepatocyte cultures have been hindered by their short life span and the rapid loss of hepatic function in vitro [14] . MSCs have become a promising type of seed cell for liver transplantation for their multiple differentiation potential, high proliferation capacity, and plastic adherence properties. However, it is difficult to determine the ideal seed cells from different types of MSCs. In the present study, we established a novel isolation and culture protocol for mouse BMSCs that could provide a large number of BMSCs in a short period of time and share a similar multiple differentiation ability with ADSCs. We also established a new HCM that not only shortens the induction time but also produces a large number of hepatocytelike cells. With the same induction system, ADSCs resembled BMSCs in term of hepatocyte differentiation potential both in vitro and in vivo.
A large quantity of ADSCs can be easily obtained by digesting adipose tissue derived from mice, rats, and humans with collagenase I [15] . However, it is difficult to obtain a large quantity of pure mouse BMSCs. We analyzed the conditioned medium method of Sun et al [16] and the compact bone method of Zhu et al [17] , and developed a novel and reliable isolation and culture method that provides a large number of BMSCs in a short period of time. Compared to the method of Sun et al [16] , the period required to obtain purified cells was shortened to 10-11 d. Compared to the method of Zhu et al [17] , we omitted the digestion step of collagenase II. Additionally, the passage time was shortened to 2 d (compared to Zhu's twice per week). Compared to the method for the isolation and culture of mouse BMSCs from bone marrow [18] , our protocol not only shows less contamination of hematopoietic lineage cells, but also obtains a large number of BMSCs in a short period of time. The number of BMSCs obtained from five mice can reach 10 7 in 10-11 d. We believe that the reason for the rapid proliferation of cells is that neonatal mice exhibit better cell viability. Therefore, we developed a novel and easy method to isolate mouse BMSCs from tibia and fibula bone fragments. Among the various hepatic differentiation systems, a one-step induction method has been most extensively applied [19] . Various cytokines and chemicals can be used to induce MSCs into hepatocyte-like cells. Current studies have reported that HGF, FGF4, EGF, OSM, Dex, aFGF, bFGF, DMSO, Vpp, and Vc can be applied for the hepatic differentiation of ADSCs [10, 20] . Additionally, HGF, FGF4, EGF, OSM, Dex, ITS, trichostatin A (TSA), and L-glutamine have been applied for the hepatic differentiation of BMSCs [21] [22] [23] [24] . In the present study, we used multiple factors, including HGF, FGF4, OSM, aFGF, bFGF, Dex, Vpp, ITS, and Vc, to develop a new induction system to promote the differentiation of MSCs. This hepatic induction system induced ADSCs and BMSCs into hepatocyte-like cells in only 10 d. However, a previously reported one-step induction system usually took more than two weeks [25] [26] . This hepatic induction system shortens the induction time compared to the previously reported one-step system. Therefore, we consider it as an optimized one-step hepatic induction system.
We also identified induced hepatocyte-like cells from ADSCs and BMSCs in terms of morphology, as well as gene and protein expression. Our results revealed a similar hepatic differentiation potential of these two cell types in vitro. In vivo, we established an animal model of acute liver failure and proved that ADSCs and BMSCs engrafted into the injured liver showed similar therapeutic effects in the improvement of liver function. The results in our study suggest that BMSCs and ADSCs may serve as ideal seed cells for treating liver injury.
In conclusion, we developed a new protocol for the preparation of mouse BMSCs and established a new hepatic induction system. Our findings proved that ADSCs resembled BMSCs in the hepatic differentiation potential in vitro and in vivo. ADSCs can be obtained more easily and are less invasive than BMSCs. Therefore, ADSCs may be a more suitable seed cell type for use in cell transplantion or liver tissue engineering. In future experiments, we will explore the roles of ADSCs in liver tissue engineering.
COMMENTS
Background
Liver transplantation remains the only effective treatment for liver failure.
However, its clinical application is limited by donor organs and immune rejection. To this end, hepatocyte transplantation and a bio-artificial liver support system are two potential surrogate complementary therapies for patients with liver failure. Hepatocyte-like cells can be induced from mesenchymal stem cells (MSCs) for xenotransplantation and have been demonstrated to perform hepatocyte functions in preclinical animal studies. However, the best type of MSCs has not yet been investigated and therefore it is important to screen for an ideal seed cell type for use in cell transplantation or a bio-artificial liver support system.
Research frontiers
MSCs are non-hematopoietic multipotent stem cells that can be isolated from multiple tissues, such as bone marrow, adipose tissue, cord blood, and amniotic fluid. Bone marrow stromal cells (BMSCs) are the most extensively studied and fertile stem cell source used in regenerative medicine and liver tissue engineering. More recently, adipose-derived stromal cells (ADSCs) were identified as another promising and extensively studied stem cells for use, especially in liver tissue engineering. Although both ADSCs and BMSCs can be induced into hepatocyte-like cells, there is no uniform culture system to evaluate their hepatic differentiation potential. Therefore, it is necessary to establish an ideal system to improve the efficiency of hepatic induction.
Innovations and breakthroughs
A new protocol for the preparation of mouse BMSCs and a new hepatic induction system were established. This study proved that ADSCs resembled BMSCs in the hepatic differentiation potential in vitro and in vivo. ADSCs can be obtained more easily and are less invasive than BMSCs. Therefore, ADSCs may serve as a more suitable seed cell type for use in cell transplantion or liver tissue engineering.
Applications
ADSCs are likely to serve as suitable seed cells for use in cell transplantion or liver tissue engineering.
Terminology
MSC transplant is a promising alternative therapy for some liver diseases. Availability of large number of functional hepatocytes is essential for cytotherapy. Both ADSCs and BMSCs can be induced into hepatocyte-like cells. Therefore, both ADSCs and BMSCs may be suitable seed cells for use in cell transplantion or liver tissue engineering.
Peer-review
In this paper, the authors investigated a novel method of generating differentiated hepatocytes from two sources of mesenchymal stem cells and tested their ability to recover liver damage in an experimental mouse model. The paper thus adressed an important question as stem cell therapy could help overcome current limitations of treatment for metabolic liver diseases and liver injury.
